Guardant Health, Inc.
GH
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancā¦ read more
Healthcare
Diagnostics & Research
7 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$161.99
Price+6.33%
$9.64
1Y
Price
Market Cap
$21.480b
Large
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-33.4%
EBITDA Margin-37.1%
Net Profit Margin-23.6%
Free Cash Flow Margin-33.4%
EBITDA Margin-37.1%
Net Profit Margin-23.6%
Free Cash Flow MarginRevenue
$1.183b
+10.0%
1y CAGR+24.6%
3y CAGR+24.8%
5y CAGREarnings
-$453.436m
-4.1%
1y CAGR+3.2%
3y CAGR+9.1%
5y CAGREPS
-$3.49
-2.1%
1y CAGR+7.2%
3y CAGR+13.7%
5y CAGRBook Value
-$222.867m
$1.912b
Assets$2.135b
Liabilities$1.669b
DebtDebt to Assets
87.3%
-4.4x
Debt to EBITDAFree Cash Flow
-$240.724m
+3.5%
1y CAGR+13.1%
3y CAGR+12.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company